Skip to main content


The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

medtronic, minimed, 670g

Highlights from the first study of a commercial automated insulin delivery device. Plus, Medtronic’s latest software updates! Continue Reading »

The artificial pancreas is here for those willing to build their own; what can manufacturers learn from OpenAPS? Continue Reading »


LEADER results announced at #2016ADA – compared to placebo, Victoza reduces risk of cardiovascular death by 22%, plus a 22% reduction in kidney disease. More results from this groundbreaking trial. Continue Reading »

People with type 2 diabetes should contact their physicians if they notice new pain, sores, or infections on their legs or feet. Continue Reading »


JDRF and Helmsley Charitable Trust workshop highlights future goals and expectations for glucose-responsive insulin. Continue Reading »


How close is the UN to achieving its goal of “halting the rise in diabetes and obesity” by 2025? Continue Reading »